Newest Topics

• Clinical Impact of Irreversible Electroporation Ablation for Unresectable Hilar by gavin
  1 day, 6 hours ago
• Is It Possible to Increase Survival of Patients With Intrahepatic Cholangiocarci by gavin
  1 day, 6 hours ago
• Cholangiocarcinoma: Diagnosis and Management by gavin
  1 day, 6 hours ago
• Effective Response of Intrahepatic Cholangiocarcinoma to Pembrolizumab: A Case R by gavin
  1 day, 6 hours ago
• Dr. Abou-Alfa on Key Eligibility Criteria for the PROOF Trial in Cholangiocarcin by gavin
  2 days, 5 hours ago
• Later-Line Infigratinib Outperforms Standard Chemotherapy in Cholangiocarcinoma by gavin
  2 days, 5 hours ago
• Clinical Impact of Irreversible Electroporation Ablation for Unresectable Hilar by gavin
  2 days, 5 hours ago
• Infigratinib Under Investigation in FGFR2-Altered Advanced Cholangiocarcinoma by gavin
  3 days, 1 hour ago
• FDA Approval Sought for Pralsetinib to Treat Advanced RET+ Thyroid Cancers by gavin
  3 days, 5 hours ago
• Efficacy With Entrectinib in NTRK+ GI Cancers Indicates a Need for More Molecula by gavin
  3 days, 5 hours ago
• Cholangiocarcinoma Metastasis to the Spine and Cranium by gavin
  6 hours, 11 minutes ago
• Prolonged Efficacy of Pembrolizumab in a Patient Presenting a Multi-Treated Meta by gavin
  3 days, 6 hours ago
• Scientists discover a new mechanism controlling liver cancer development by gavin
  4 days, 4 hours ago
• Towards Standardization of Liver Resections in India: Five Hundred Consecutive O by gavin
  4 days, 4 hours ago
• New Treatment Options for Advanced Biliary Tract Cancer by gavin
  4 days, 4 hours ago
• Percutaneous Transhepatic Placement of Plastic Biliary Stents: Technical Descrip by gavin
  4 days, 4 hours ago